EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
MIT Technology Review·6d ago·5 min read
Weight-loss drugs show signs of slowing biological aging, say drugmakers
TL;DR
Weight-loss drugs from Eli Lilly and Novo Nordisk may not only aid in weight loss but also slow biological aging, showing a reduction in biological age by two to three years in patients compared to a placebo.
✦ Why It Matters
Consider discussing GLP-1 drugs with patients who are overweight or diabetic to explore potential benefits beyond weight loss.
Key Takeaways
- Explore GLP-1 drugs for weight management and potential anti-aging effects.
- Stay informed about ongoing studies on semaglutide's effects in healthy individuals.
- Discuss with healthcare providers about the risks and benefits of GLP-1 medications.
- Monitor developments in aging clock research for future health insights.
How It Works
GLP-1 drugs stimulate receptors that signal the brain to reduce hunger, leading to weight loss. They also appear to influence biological aging by affecting molecular markers associated with age, such as DNA changes and protein levels.